CD4 and acute myeloid leukemia: The clinical significance of this is revealed by the differences in CD4+ effector T cell activation, as measured by IFNγ production, following co-culture of either diagnostic or post-transplantation relapsed AML samples with CD4+ T cells, as CD4+ T cell activity was diminished in post-transplantation relapse co-culture assays[33].